Comment on Saner et al. The Yin and the Yang of Hemostasis in End-Stage Liver Disease. J. Clin. Med. 2023, 12, 5759

Bruce D. Spiess,Wim P. M. Houdijk

DOI: https://doi.org/10.3390/jcm13061666

IF: 3.9

2024-03-15

Journal of Clinical Medicine

Abstract:We congratulate you on a quality review of the article on hemostasis in end-stage liver disease by Saner FH et al [...]

medicine, general & internal

What problem does this paper attempt to address?

Letter to the Editor: Risk Stratification in Patients With Child-Pugh B Cirrhosis and Acute Variceal Bleeding

Yuan-Fei Shi,Wan-Zhuo Xie

DOI: https://doi.org/10.1002/hep.32013

IF: 17.298

2021-01-01

Hepatology

Abstract:We recently read with great interest the article published by Yong Lv et al. in an issue of Hepatology. The authors demonstrated the risk stratification based on chronic liver failure consortium acute decompensation score in patients with child-pugh B cirrhosis and acute variceal bleeding. We firmly appreciate the contributions of the authors in the subject. Nevertheless, some concerns should be addressed with due attention.
Letter to the Editor: Risk Stratification in Patients with Child‐Pugh B Cirrhosis and Acute Variceal Bleeding

Yuanfei Shi,Wanzhuo Xie

DOI: https://doi.org/10.1002/hep.32013

IF: 17.298

2021-01-01

Hepatology

Abstract:HepatologyVolume 74, Issue 5 p. 2917-2919 Correspondence Letter to the Editor: Risk Stratification in Patients With Child-Pugh B Cirrhosis and Acute Variceal Bleeding Yuan‑Fei Shi M.D., Ph.D., Yuan‑Fei Shi M.D., Ph.D. Department of Hematology, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, ChinaSearch for more papers by this authorWan‑Zhuo Xie M.D., Ph.D., Wan‑Zhuo Xie M.D., Ph.D. Department of Hematology, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, ChinaSearch for more papers by this author Yuan‑Fei Shi M.D., Ph.D., Yuan‑Fei Shi M.D., Ph.D. Department of Hematology, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, ChinaSearch for more papers by this authorWan‑Zhuo Xie M.D., Ph.D., Wan‑Zhuo Xie M.D., Ph.D. Department of Hematology, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, ChinaSearch for more papers by this author First published: 15 June 2021 https://doi.org/10.1002/hep.32013 Potential conflict of interest: Nothing to report. Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinked InRedditWechat No abstract is available for this article. Volume74, Issue5November 2021Pages 2917-2919 RelatedInformation
Editorial: Advances in Extracorporeal Life Support in Critically Ill Patients, Volume III

Guo-wei Tu,Nikola Dobrilovic,Man Huang,Zhe Luo

DOI: https://doi.org/10.3389/fmed.2024.1394830

IF: 3.9

2024-01-01

Frontiers in Medicine

Abstract:COPYRIGHT © 2023 Tu, Chen, Huang, Dobrilovic and Luo. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. Editorial: Advances in extracorporeal life support in critically ill patients, volume II
Corrigendum to “artificial Liver Support System Improves Short-Term Outcomes of Patients with HBV-Associated Acute-on-Chronic Liver Failure: A Propensity Score Analysis”

Lanlan Xiao,Xingqi Xu,Kaizhou Huang,Yalei Zhao,Lingjian Zhang,Lanjuan Li

DOI: https://doi.org/10.1155/2021/9875940

2021-01-01

BioMed Research International

Abstract:[This corrects the article DOI: 10.1155/2019/3757149.].
Corrigendum: Impact of Serum Uric Acid Lowering and Contemporary Uric Acid-Lowering Therapies on Cardiovascular Outcomes: A Systematic Review and Meta-Analysis.

Hangying Ying,Hongdi Yuan,Xiaomei Tang,Wenpu Guo,Ruhong Jiang,Chenyang Jiang

DOI: https://doi.org/10.3389/fcvm.2021.723626

IF: 3.6

2021-01-01

Frontiers in Cardiovascular Medicine

Abstract:[This corrects the article DOI: 10.3389/fcvm.2021.641062.].
Comment on Polak et al. Principles and Limitations of miRNA Purification and Analysis in Whole Blood Collected during Ablation Procedure from Patients with Atrial Fibrillation. J. Clin. Med. 2024, 13, 1898

Kehinde Ross

DOI: https://doi.org/10.3390/jcm13133671

IF: 3.9

2024-06-24

Journal of Clinical Medicine

Abstract:JCM, Vol. 13, Pages 3671: Comment on Polak et al. Principles and Limitations of miRNA Purification and Analysis in Whole Blood Collected during Ablation Procedure from Patients with Atrial Fibrillation. J. Clin. Med. 2024, 13, 1898 Journal of Clinical Medicine doi: 10.3390/jcm13133671 Authors: Kehinde Ross In the current issue of the journal, the paper by Polak et al [...]

medicine, general & internal
Hemostatic balance in patients with liver cirrhosis: Report of a consensus conference

Under the auspices of the Italian Association for the Study of Liver Diseases (AISF) and the Italian Society of Internal Medicine (SIMI),Angelo Andriulli,Armando Tripodi,Paolo Angeli,Marco Senzolo,Massimo Primignani,Edoardo G Giannini,Oliviero Riggio,Agostino Colli,Daniele Prati,David Sacerdoti,Carlo Merkel,Stefania Basili,Domenico Ferro,Erica Villa,Giovanni Di Minno,Paolo Caraceni,Marco Marzioni,Pier Mannuccio Mannucci,Francesco Violi,Fabio Piscaglia,Vincenza Calvaruso,Lesley De Pietri,Marco Falcone,Paolo Feltracco,Elvira Grandone,Vincenzo La Mura,Anna Licata,Cristina Lucidi,Sergio Maimone,Marco Marietta,Filomena Morisco,Laura Napoleone,Salvatore Piano,Valeria Raparelli,Paolo Rebulla,Dario Ribero,Maria Teresa Sartori,Antonella Scalera,Filippo Schepis,Massimo Siciliano,Gianluca Svegliati Baroni,Antonella Tufano,Alessandro Vitale,Massimo Zuin

DOI: https://doi.org/10.1016/j.dld.2016.02.008

Abstract:Patients with cirrhosis present with hemostatic alterations secondary to reduced availability of pro-coagulant and anti-coagulant factors. The net effect of these changes is a rebalanced hemostatic system. The Italian Association of the Study of the Liver (AISF) and the Italian Society of Internal Medicine (SIMI) promoted a consensus conference on the hemostatic balance in patients with cirrhosis. The consensus process started with the review of the literature by a scientific board of experts and ended with a formal consensus meeting in Rome in December 2014. The statements were graded according to quality of evidence and strength of recommendations, and approved by an independent jury. The statements presented here highlight strengths and weaknesses of current laboratory tests to assess bleeding and thrombotic risk in cirrhotic patients, the pathophysiology of hemostatic perturbations in this condition, and outline the optimal management of bleeding and thrombosis in patients with liver cirrhosis.
Comments on: Perioperative von Willebrand factor dynamics are associated with liver regeneration and predict outcome after liver resection

Jia-Jia Chen,Lan-Juan Li

DOI: https://doi.org/10.1016/j.hbpd.2018.09.020

IF: 3.355

2018-01-01

Hepatobiliary & Pancreatic Diseases International

Abstract:Recentlythearticle"PerioperativevonWillebrandfactordynamics are associated with liver regeneration and predict outcome afterliver resection" was published in Hepatology[1].Prof.Starlinger et al. aimed to assess the association of von Willebrand factor （vWF） levels and clinical outcome in patients with liver cancers post-liverresection（LR）.Basedonthemechanismthatplatelets accumulation in the liver may promote liver regeneration after partial LR in mice, they found the vWF-dependent pattern of platelets accumulationduringliverregenerationinpatientsaftersurgery.
Exploring Haematological Complications in Cirrhosis of the Liver: A Comprehensive Review

Parav Tantia,Parth Aggarwal,Sourya Acharya,Sunil Kumar,Manjeet Kothari,Abhinav Kadam,Rajvardhan Patil

DOI: https://doi.org/10.7759/cureus.65319

2024-07-24

Cureus

Abstract:Various chronic liver diseases inevitably end up with cirrhosis of the liver, and this comes with a whole range of haematological complications. Therefore, this detailed review has discussed pathophysiology, clinical manifestations, diagnostic measures, and treatment plans for these anomalies. Closely related are conditions such as anaemia, thrombocytopenia, coagulopathy, leukopenia, and haemolytic disorders, which are known to contribute to morbidity and mortality in cirrhotic patients significantly. Therefore, we need to understand the causes of these problems to find ways of helping our patients better. For this reason, multidisciplinary management will be key in ensuring proper monitoring, timely intervention, and preventive measures for haematological abnormalities in cirrhosis. Additionally, there have been tremendous advancements in therapeutic options, like adjunctive therapies or haematopoietic growth factors, which hold much promise regarding patient outcomes. This article emphasizes the proactive management of haematological complications associated with cirrhosis while highlighting the need for further research coupled with collaboration aimed at strengthening prevention strategies, diagnostic methods, and curative interventions.
Comment on Levitt et al. Approach to Decompensated Right Heart Failure in the Acute Setting. J. Clin. Med. 2024, 13, 869

Carolina Brea,Ellen Freeh,Michael I Prats

DOI: https://doi.org/10.3390/jcm13133848

2024-06-29

Abstract:We read with great interest the article titled "Approach to Decompensated Right Heart Failure in the Acute Setting" [...].
Balanced haemostasis with both hypo- and hyper-coagulable features in critically ill patients with acute-on-chronic-liver failure

Caleb Fisher,Vishal C Patel,Sidsel Hyldgaard Stoy,Arjuna Singanayagam,Jelle Adelmeijer,Julia Wendon,Debbie L Shawcross,Ton Lisman,William Bernal

DOI: https://doi.org/10.1016/j.jcrc.2017.07.053

Abstract:Background: Cirrhotic patients have complex haemostatic abnormalities. Current evidence suggests stable cirrhotic (SC) patients have a "re-balanced" haemostatic state. However, limited data exists in acute decompensated (AD) or acute on chronic liver failure (ACLF) patients. Methods: We utilised thrombin generation analysis, fibrinolysis assessment, and evaluation of haemostatic parameters to assess haemostasis in liver disease of progressive severity. Results: The study cohorts were comprised of: SC, n=8; AD n=44; ACLF, n=17; and Healthy Control (HC), n=35. There was a progressive increase across the cohorts in INR (p=0.0001), Factor VIII (p=0.0001) and VWF levels (p=0.0001) and a correspondingly decrease in anti-thrombin (p=0.0001), ADAMTS-13 (p=0.01) and fibrinogen levels (p=0.0001). In the presence of thrombomodulin, thrombin generation was equivalent or significantly higher in all the cohorts compared to HC (p=0.0001). Compared to AD, ACLF had a lower ETP (p=0.002) and thrombin peak (p=0.0001). There was no significant difference across the cohorts in clot lysis time (p=0.07), although compared to HC, AD had a significantly shorter lysis time (p=0.001). Conclusions: Our cohorts, despite significant differences in haemostatic parameters, displayed intact thrombin generation but progressive hypo-functional clot stability and potentially but not universal hyper-functional haemostasis.
Four Decades of Clinical Liver Transplantation Research: Results of a Comprehensive Bibliometric Analysis

Decan Jiang,Tengfei Ji,Wenjia Liu,Jan Bednarsch,Markus Selzner,Johann Pratschke,Georg Lurje,Tiansheng Cao,Isabel M A Brüggenwirth,Paulo N Martins,Sven Arke Lang,Ulf Peter Neumann,Zoltan Czigany

DOI: https://doi.org/10.1097/TP.0000000000004224

2022-10-01

Transplantation

Abstract:Background: Nearly 40 y have passed since the 1983 National Institutes of Health Consensus-Development-Conference, which has turned liver transplantation (LT) from a clinical experiment into a routine therapeutic modality. Since' clinical LT has changed substantially. We aimed to comprehensively analyze the publication trends in the most-cited top-notch literature in LT science over a 4-decade period. Methods: A total of 106 523 items were identified between January 1981 and May 2021 from the Web of Science Core Collection. The top 100 articles published were selected using 2 distinct citation-based strategies to minimize bias. Various bibliometric tools were used for data synthesis and visualization. Results: The citation count for the final dataset of the top 100 articles ranged from 251 to 4721. Most articles were published by US authors (n = 61). The most prolific institution was the University of Pittsburgh (n = 15). The highest number of articles was published in Annals of Surgery, Hepatology, and Transplantation ; however, Hepatology publications resulted in the highest cumulative citation of 9668. Only 10% of the articles were classified as evidence level 1. Over 90% of first/last authors were male. Our data depict the evolution of research focus over 40 y. In part, a disproportional flow of citations was observed toward already well-cited articles. This might also project a slowed canonical progress, which was described in other fields of science. Conclusions: This study highlights key trends based on a large dataset of the most-cited articles over a 4-decade period. The present analysis not only provides an important cross-sectional and forward-looking guidance to clinicians, funding bodies, and researchers but also draws attention to important socio-academic or demographic aspects in LT.
Assessment and management of coagulopathy in critically-ill patients with liver failure

Fuat H Saner,Dmitri Bezinover,Fuat H. Saner

DOI: https://doi.org/10.1097/MCC.0000000000000591

2019-10-07

Current Opinion in Critical Care

Abstract:Purpose of review This review provides insight into our current understanding of the pathophysiology and treatment of coagulopathy associated with liver failure, and bleeding risk assessment. Recent findings Patients with end-stage liver disease (ESLD) have a rebalanced coagulation profile and are at risk for both excessive clotting and bleeding. Hypercoagulability is associated with profound endothelial dysfunction and an increased concentration of liver-independent coagulation factors. Because of this rebalanced coagulation profile, standard laboratory tests have been demonstrated to be ineffective in either predicting and/or guiding the management of coagulopathy. Viscoelastic testing, however, is able to provide a dynamic assessment of clot formation in whole blood and has been demonstrated to be invaluable in both monitoring and management of coagulation problems associated with liver failure. More recently, there is increasing interest in thrombin generation tests to monitor coagulation in patients with ESLD. Multiple institutional protocols for prophylaxis and treatment of ESLD-related thromboses have been developed. High-quality studies evaluating these approaches are lacking. Summary Patients with ESLD are at risk for excessive bleeding and clotting. Treatment of any significant coagulopathy should not be based solely on standard laboratory tests. Thrombosis prophylaxis has to be considered in susceptible populations.

critical care medicine
Editorial: Redefining liver health—Personalised approach to assessment of serum ALT in clinical practice. Authors' reply

Eunice X. X. Tan,Daniel Q. Huang,Mindie H. Nguyen

DOI: https://doi.org/10.1111/apt.18112

IF: 9.524

2024-06-14

Alimentary Pharmacology & Therapeutics

Abstract:LINKED CONTENT This article is linked to Eunice et al papers. To view these articles, visit https://doi.org/10.1111/apt.17914 and https://doi.org/10.1111/apt.17951

pharmacology & pharmacy,gastroenterology & hepatology
Reply to Ott, M.; Werneke, U. Comment on "Liu et al. Hemodialysis Treatment for Patients with Lithium Poisoning. Int. J. Environ. Res. Public Health 2022, 19, 10044"

Yu-Hsin Liu,Tzung-Hai Yen

DOI: https://doi.org/10.3390/ijerph20115951

IF: 4.614

2023-05-26

International Journal of Environmental Research and Public Health

Abstract:We would like to thank Professor Ott and Professor Werneke for their helpful comments [...]

public, environmental & occupational health,environmental sciences
Response to Chen et al and the Accompanying Commentary

Adnan Sharif,David McGiffin,Russell Strong,Torsten Trey,David Matas,Jacob Lavee,Susie Hughes,Wendy Rogers

DOI: https://doi.org/10.1097/tp.0000000000005005

2024-05-31

Transplantation

Abstract:We question the decision by Transplantation to publish the article by Chen et al 1 in relation to the development of liver transplantation at the Sun Yat-sen First Affiliated Hospital. Furthermore, the accompanying Commentary by Ascher and Delmonico 2 provides unverified assurances that fail to acknowledge the body of evidence.

immunology,surgery,transplantation
A Single‐Cell Perspective of the Mammalian Liver in Health and Disease

Xuelian Xiong,Henry Kuang,Tongyu Liu,Jiandie D. Lin

DOI: https://doi.org/10.1002/hep.31149

IF: 17.298

2020-01-01

Hepatology

Abstract:HepatologyVolume 71, Issue 4 p. 1467-1473 Concise Review A Single-Cell Perspective of the Mammalian Liver in Health and Disease Xuelian Xiong, Xuelian Xiong Life Sciences Institute and Department of Cell & Developmental Biology, University of Michigan Medical Center, Ann Arbor, MI Ministry of Education Key Laboratory of Metabolism and Molecular Medicine, Department of Endocrinology and Metabolism, Zhongshan Hospital, Fudan University, Shanghai, ChinaSearch for more papers by this authorHenry Kuang, Henry Kuang Life Sciences Institute and Department of Cell & Developmental Biology, University of Michigan Medical Center, Ann Arbor, MISearch for more papers by this authorTongyu Liu, Tongyu Liu Life Sciences Institute and Department of Cell & Developmental Biology, University of Michigan Medical Center, Ann Arbor, MISearch for more papers by this authorJiandie D. Lin, Corresponding Author Jiandie D. Lin jdlin@umich.edu orcid.org/0000-0001-8069-5647 Life Sciences Institute and Department of Cell & Developmental Biology, University of Michigan Medical Center, Ann Arbor, MI Address Correspondence and Reprint Requests to: Jiandie Lin, Ph.D. 5437 Life Sciences Institute, University of Michigan 210 Washtenaw Avenue Ann Arbor, MI 48109 E-mail: jdlin@umich.edu Tel.: +1-734-615-3512Search for more papers by this author Xuelian Xiong, Xuelian Xiong Life Sciences Institute and Department of Cell & Developmental Biology, University of Michigan Medical Center, Ann Arbor, MI Ministry of Education Key Laboratory of Metabolism and Molecular Medicine, Department of Endocrinology and Metabolism, Zhongshan Hospital, Fudan University, Shanghai, ChinaSearch for more papers by this authorHenry Kuang, Henry Kuang Life Sciences Institute and Department of Cell & Developmental Biology, University of Michigan Medical Center, Ann Arbor, MISearch for more papers by this authorTongyu Liu, Tongyu Liu Life Sciences Institute and Department of Cell & Developmental Biology, University of Michigan Medical Center, Ann Arbor, MISearch for more papers by this authorJiandie D. Lin, Corresponding Author Jiandie D. Lin jdlin@umich.edu orcid.org/0000-0001-8069-5647 Life Sciences Institute and Department of Cell & Developmental Biology, University of Michigan Medical Center, Ann Arbor, MI Address Correspondence and Reprint Requests to: Jiandie Lin, Ph.D. 5437 Life Sciences Institute, University of Michigan 210 Washtenaw Avenue Ann Arbor, MI 48109 E-mail: jdlin@umich.edu Tel.: +1-734-615-3512Search for more papers by this author First published: 30 January 2020 https://doi.org/10.1002/hep.31149Citations: 9 Potential conflict of interest: Nothing to report. Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinked InRedditWechat Citing Literature Volume71, Issue4April 2020Pages 1467-1473 RelatedInformation
Establishment of Review Criteria for a Hematology Analyzer with an Automated Review Function

Wei Wu,Yan Huang,Yuqing Pei,J. Y. Li,F. Wang,G. Wang,Lili Mao,X. Wang,Wei Cui

DOI: https://doi.org/10.1111/ijlh.12487

2016-01-01

International Journal of Laboratory Hematology

Abstract:International Journal of Laboratory HematologyVolume 38, Issue 3 p. e60-e64 Letter to the Editor Establishment of review criteria for a hematology analyzer with an automated review function W. Wu, W. Wu The Department of Clinical Laboratory, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, ChinaSearch for more papers by this authorY. Huang, Y. Huang The Department of Clinical Laboratory, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, ChinaSearch for more papers by this authorY. Q. Pei, Y. Q. Pei The Department of Clinical Laboratory, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, ChinaSearch for more papers by this authorJ. Y. Li, J. Y. Li The Department of Clinical Laboratory, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, ChinaSearch for more papers by this authorF. Wang, F. Wang The Department of Clinical Laboratory, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, ChinaSearch for more papers by this authorG. Wang, G. Wang The Department of Clinical Laboratory, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, ChinaSearch for more papers by this authorL. L. Mao, L. L. Mao The Department of Clinical Laboratory, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, ChinaSearch for more papers by this authorX. Wang, X. Wang The Department of Clinical Laboratory, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, ChinaSearch for more papers by this authorW. Cui, W. Cui cuiw@pumch.cn The Department of Clinical Laboratory, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, ChinaSearch for more papers by this author W. Wu, W. Wu The Department of Clinical Laboratory, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, ChinaSearch for more papers by this authorY. Huang, Y. Huang The Department of Clinical Laboratory, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, ChinaSearch for more papers by this authorY. Q. Pei, Y. Q. Pei The Department of Clinical Laboratory, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, ChinaSearch for more papers by this authorJ. Y. Li, J. Y. Li The Department of Clinical Laboratory, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, ChinaSearch for more papers by this authorF. Wang, F. Wang The Department of Clinical Laboratory, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, ChinaSearch for more papers by this authorG. Wang, G. Wang The Department of Clinical Laboratory, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, ChinaSearch for more papers by this authorL. L. Mao, L. L. Mao The Department of Clinical Laboratory, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, ChinaSearch for more papers by this authorX. Wang, X. Wang The Department of Clinical Laboratory, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, ChinaSearch for more papers by this authorW. Cui, W. Cui cuiw@pumch.cn The Department of Clinical Laboratory, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, ChinaSearch for more papers by this author First published: 29 March 2016 https://doi.org/10.1111/ijlh.12487Citations: 1 W. Wu and Y. Huang contribute equally to the article. Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat Citing Literature Volume38, Issue3June 2016Pages e60-e64 RelatedInformation
Systematic review: the model for end‐stage liver disease – should it replace Child‐Pugh's classification for assessing prognosis in cirrhosis?

M. Vangeli,A. K. Burroughs,G. Papatheodoridis,D. Patch,E. Cholongitas,N. Terreni

DOI: https://doi.org/10.1111/j.1365-2036.2005.02691.x

2005-12-01

Abstract:Background: Prognosis in cirrhotic patients has had a resurgence of interest because of liver transplantation and new therapies for complications of end‐stage cirrhosis. The model for end‐stage liver disease score is now used for allocation in liver transplantation waiting lists, replacing Child‐Turcotte‐Pugh score. However, there is debate as whether it is better in other settings of cirrhosis.

Medicine
Addressing the Complexities of Pre-Liver Transplant Immune Checkpoint Inhibitors for Hepatocellular Carcinoma: A Response to Recent Commentaries

Mohammad Saeid Rezaee-Zavareh,Zhiyong Guo,Ju Dong Yang

DOI: https://doi.org/10.1016/j.jhep.2024.09.019

IF: 25.7

2024-09-20

Journal of Hepatology

Abstract:Concept and Design: MSR-Z, ZG, JDY. Data Acquisition and/ or Interpretation : MSR-Z, ZG, JDY. Drafting the Manuscript : MSR-Z. Critical Revision : ZG, JDY. Final Approval and Agreement : All Authors.

gastroenterology & hepatology

Comment on Saner et al. The Yin and the Yang of Hemostasis in End-Stage Liver Disease. J. Clin. Med. 2023, 12, 5759

Letter to the Editor: Risk Stratification in Patients With Child-Pugh B Cirrhosis and Acute Variceal Bleeding

Letter to the Editor: Risk Stratification in Patients with Child‐Pugh B Cirrhosis and Acute Variceal Bleeding

Editorial: Advances in Extracorporeal Life Support in Critically Ill Patients, Volume III

Corrigendum to “artificial Liver Support System Improves Short-Term Outcomes of Patients with HBV-Associated Acute-on-Chronic Liver Failure: A Propensity Score Analysis”

Corrigendum: Impact of Serum Uric Acid Lowering and Contemporary Uric Acid-Lowering Therapies on Cardiovascular Outcomes: A Systematic Review and Meta-Analysis.

Comment on Polak et al. Principles and Limitations of miRNA Purification and Analysis in Whole Blood Collected during Ablation Procedure from Patients with Atrial Fibrillation. J. Clin. Med. 2024, 13, 1898

Hemostatic balance in patients with liver cirrhosis: Report of a consensus conference

Comments on: Perioperative von Willebrand factor dynamics are associated with liver regeneration and predict outcome after liver resection

Exploring Haematological Complications in Cirrhosis of the Liver: A Comprehensive Review

Comment on Levitt et al. Approach to Decompensated Right Heart Failure in the Acute Setting. J. Clin. Med. 2024, 13, 869

Balanced haemostasis with both hypo- and hyper-coagulable features in critically ill patients with acute-on-chronic-liver failure

Four Decades of Clinical Liver Transplantation Research: Results of a Comprehensive Bibliometric Analysis

Assessment and management of coagulopathy in critically-ill patients with liver failure

Editorial: Redefining liver health—Personalised approach to assessment of serum ALT in clinical practice. Authors' reply

Reply to Ott, M.; Werneke, U. Comment on "Liu et al. Hemodialysis Treatment for Patients with Lithium Poisoning. Int. J. Environ. Res. Public Health 2022, 19, 10044"

Response to Chen et al and the Accompanying Commentary

A Single‐Cell Perspective of the Mammalian Liver in Health and Disease

Establishment of Review Criteria for a Hematology Analyzer with an Automated Review Function

Systematic review: the model for end‐stage liver disease – should it replace Child‐Pugh's classification for assessing prognosis in cirrhosis?

Addressing the Complexities of Pre-Liver Transplant Immune Checkpoint Inhibitors for Hepatocellular Carcinoma: A Response to Recent Commentaries